| http://www.w3.org/ns/prov#value | - hree key concepts: ???exposure and response assessment, evaluation of residual uncertainty, and assumptions about analytical quality and similarity, are especially relevant to development of proposed biosimilar products.???If these criteria are addressed, through the submission of convincing PK and PD results, the FDA says, then ???the extent of the clinical development program can be refined in b
|
